Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact

Subscribe

Registers› Irish medicines ›Janssen-Cilag International NV

Medicines register · Ireland

Janssen-Cilag International NV — licensed medicines

99 medicines held by Janssen-Cilag International NV on the Irish market, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,295 authorised products are in this register. Synced 06 Oct 2026, 03:23 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Spravato 28 mg nasal spray, solution EU/1/19/1410/001-004

ESKETAMINE HYDROCHLORIDE, Esketamine

Janssen-Cilag International NV

—

STELARA 130 mg Concentrate for solution for infusion EU/1/08/494/005

Ustekinumab

Janssen-Cilag International NV

—

STELARA 45 mg Solution for injection EU/1/08/494/003

Ustekinumab

Janssen-Cilag International NV

—

STELARA 45 mg Solution for injection EU/1/08/494/001

Ustekinumab

Janssen-Cilag International NV

—

STELARA 90 mg Solution for injection EU/1/08/494/004

Ustekinumab

Janssen-Cilag International NV

—

Symtuza 800 mg/150 mg/200 mg/10 mg film-coated tablets EU/1/17/1225/001

Tenofovir alafenamide, Darunavir ethanolate, Emtricitabine, Cobicistat

Janssen-Cilag International NV

—

TALVEY 2 mg/mL solution for injection EU/1/23/1748/001

Talquetamab

Janssen-Cilag International NV

—

TALVEY 40 mg/mL solution for injection EU/1/23/1748/002

Talquetamab

Janssen-Cilag International NV

—

TECVAYLI 10 mg/mL solution for injection EU/1/22/1675/001

Teclistamab

Janssen-Cilag International NV

—

TECVAYLI 90 mg/mL solution for injection EU/1/22/1675/002

Teclistamab

Janssen-Cilag International NV

—

Tracleer 125 mg film-coated tablets EU/1/02/220/004

Bosentan

Janssen-Cilag International NV

—

Tracleer 125 mg film-coated tablets EU/1/02/220/005

Bosentan

Janssen-Cilag International NV

—

Tracleer 32 mg dispersible tablets EU/1/02/220/006

Bosentan

Janssen-Cilag International NV

—

Tracleer 62.5 mg film-coated tablets EU/1/02/220/001

Bosentan

Janssen-Cilag International NV

—

Tracleer 62.5 mg film-coated tablets EU/1/02/220/002

Bosentan

Janssen-Cilag International NV

—

Tracleer 62.5 mg film-coated tablets EU/1/02/220/003

Bosentan

Janssen-Cilag International NV

—

Tremfya 100 mg Solution for injection pre-filled syringe EU/1/17/1234/001

Guselkumab

Janssen-Cilag International NV

—

Tremfya 200 mg Solution for injection pre-filled pen EU/1/17/1234/008-009

Guselkumab

Janssen-Cilag International NV

—

Tremfya 200 mg Solution for injection pre-filled syringe EU/1/17/1234/006-007

Guselkumab

Janssen-Cilag International NV

—

Tremfya 45 mg/0.45 mL solution for injection in pre-filled pen EU/1/17/1234/012

Guselkumab

Janssen-Cilag International NV

—

Trevicta 175mg Prolonged-release suspension for injection EU/1/14/971/007

Paliperidone palmitate (r092670)

Janssen-Cilag International NV

—

Trevicta 263mg Prolonged-release suspension for injection EU/1/14/971/008

Paliperidone palmitate (r092670)

Janssen-Cilag International NV

—

Trevicta 350mg Prolonged-release suspension for injection EU/1/14/971/009

Paliperidone palmitate (r092670)

Janssen-Cilag International NV

—

Trevicta 525mg Prolonged-release suspension for injection EU/1/14/971/010

Paliperidone palmitate (r092670)

Janssen-Cilag International NV

—

Uptravi 100 microgram film-coated tablets EU/1/15/1083/012-013

Selexipag

Janssen-Cilag International NV

—

Uptravi 1000 microgram film-coated tablets EU/1/15/1083/007

Selexipag

Janssen-Cilag International NV

—

Uptravi 1200 microgram film-coated tablets EU/1/15/1083/008

Selexipag

Janssen-Cilag International NV

—

Uptravi 1400 microgram film-coated tablets EU/1/15/1083/009

Selexipag

Janssen-Cilag International NV

—

Uptravi 1600 microgram film-coated tablets EU/1/15/1083/010

Selexipag

Janssen-Cilag International NV

—

Uptravi 200 microgram film-coated tablets EU/1/15/1083/001-003

Selexipag

Janssen-Cilag International NV

—

Uptravi 400 microgram film-coated tablets EU/1/15/1083/004

Selexipag

Janssen-Cilag International NV

—

Uptravi 600 microgram film-coated tablets EU/1/15/1083/005

Selexipag

Janssen-Cilag International NV

—

Uptravi 800 microgram film-coated tablets EU/1/15/1083/006

Selexipag

Janssen-Cilag International NV

—

Velcade 1 mg powder for solution for injection EU/1/04/274/002

Ps-341 as boronic acid (bortezomib)

Janssen-Cilag International NV

—

Velcade 3.5 mg powder for solution for injection EU/1/04/274/001

Bortezomib

Janssen-Cilag International NV

—

Veletri 0.5 Milligram Powder for Solution for Infusion PA0885/001/001

EPOPROSTENOL SODIUM

Janssen-Cilag International NV

Marketed

Veletri 1.5 Milligram Powder for Solution for Infusion PA0885/001/002

EPOPROSTENOL SODIUM

Janssen-Cilag International NV

Marketed

Vokanamet 150 mg/1000 mg Film-coated tablet EU/1/14/918/010-012

Purified water, Hypromellose 2910, 15 mpa.s, Canagliflozin, Croscarmellose sodium, MICROCRYSTALLINE CELLULOSE

Janssen-Cilag International NV

—

Vokanamet 150 mg/850 mg Film-coated tablet EU/1/14/918/007-009

MICROCRYSTALLINE CELLULOSE, Croscarmellose sodium, Canagliflozin, Purified water, Metformin Hydrochloride

Janssen-Cilag International NV

—

Vokanamet 50 mg/1000 mg Film-coated tablet EU/1/14/918/004-006

Metformin Hydrochloride, MICROCRYSTALLINE CELLULOSE, Hypromellose 2910, 15 mpa.s, Purified water, Croscarmellose sodium

Janssen-Cilag International NV

—

Vokanamet 50 mg/850 mg Film-coated tablet EU/1/14/918/001-003

Metformin Hydrochloride, Purified water, Croscarmellose sodium, Hypromellose 2910, 15 mpa.s, MICROCRYSTALLINE CELLULOSE

Janssen-Cilag International NV

—

Xeplion 100 mg prolonged-release suspension for injection EU/1/11/672/004

Paliperidone palmitate (r092670)

Janssen-Cilag International NV

—

Xeplion 150 mg prolonged-release suspension for injection EU/1/11/672/005

Paliperidone palmitate (r092670)

Janssen-Cilag International NV

—

Xeplion 150 mg prolonged-release suspension for injection Xeplion 100 mg prolonged-release suspension for injection EU/1/11/672/006

Paliperidone, Paliperidone

Janssen-Cilag International NV

—

Xeplion 25 mg prolonged-release suspension for injection EU/1/11/672/001

Paliperidone palmitate (r092670)

Janssen-Cilag International NV

—

Xeplion 50 mg prolonged-release suspension for injection EU/1/11/672/002

Paliperidone palmitate (r092670)

Janssen-Cilag International NV

—

Xeplion 75 mg prolonged-release suspension for injection EU/1/11/672/003

Paliperidone palmitate (r092670)

Janssen-Cilag International NV

—

ZYTIGA 250 mg tablets EU/1/11/714/001

Abiraterone acetate

Janssen-Cilag International NV

—

ZYTIGA 500 mg tablets EU/1/11/714/002-003

Abiraterone acetate

Janssen-Cilag International NV

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 6 October 2026. https://priyalifescience.com/medicines/company/janssen-cilag-international-nv

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.